Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REFERENCES<br />
Papapetropoulos T., Johnson W. G., Lazzar<strong>in</strong>i A. M., Duvois<strong>in</strong> R. C., Di Iorio G., Golbe L. I.<br />
and Nussbaum R. L. (1997) Mutation <strong>in</strong> the alpha-synucle<strong>in</strong> gene identified <strong>in</strong> families with<br />
Park<strong>in</strong>son’s disease. Science 276, 2045–2047.<br />
Potth<strong>of</strong>f M. J. and Olson E. N. (2007) MEF2: a central regulator <strong>of</strong> diverse developmental<br />
programs. Development 134, 4131–4140.<br />
Powell J. J. and Thompson R. P. (1993) The chemistry <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> <strong>in</strong> the gastro<strong>in</strong>test<strong>in</strong>al<br />
lumen and its uptake and absorption. Proc. Nutr. Soc. 52, 241–253.<br />
Powell J. J., Greenfield S. M., Parkes H. G., Nicholson J. K. and Thompson R. P. (1993) Gastro-<br />
<strong>in</strong>test<strong>in</strong>al availability <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> from tea. Food Chem. Toxicol. 31, 449–454.<br />
Price K. S., Farley I. J. and Hornykiewicz O. (1978) Neurochemistry <strong>of</strong> Park<strong>in</strong>son’s disease:<br />
relation between striatal and limbic dopam<strong>in</strong>e. Adv. Biochem. Psychopharmacol. 19, 293–<br />
300.<br />
Priest N. D. (2004) The biological behaviour and bioavailability <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> <strong>in</strong> man, with<br />
special reference to studies employ<strong>in</strong>g <strong>alum<strong>in</strong>ium</strong>-26 as a tracer: review and study update.<br />
J. Environ. Monit. 6, 375–403.<br />
Priest N. D., Newton D., Day J. P., Talbot R. J. and Warner A. J. (1995) Human metabolism <strong>of</strong><br />
<strong>alum<strong>in</strong>ium</strong>-26 and gallium-67 <strong>in</strong>jected as citrates. Hum. Exp. Toxicol. 14, 287–293.<br />
Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D. and Togasaki<br />
D. M. (1995) Dose-dependent lesions <strong>of</strong> the dopam<strong>in</strong>ergic nigrostriatal pathway <strong>in</strong>duced<br />
by <strong>in</strong>trastriatal <strong>in</strong>jection <strong>of</strong> 6-hydroxydopam<strong>in</strong>e. Neuroscience 67, 631–647.<br />
Priyadarshi A., Khuder S. A., Schaub E. A. and Priyadarshi S. S. (2001) Environmental risk factors<br />
and Park<strong>in</strong>son’s disease: a metaanalysis. Environ. Res. 86, 122–127.<br />
Probst A., Bloch A. and Tolnay M. (2008) New <strong>in</strong>sights <strong>in</strong>to the pathology <strong>of</strong> Park<strong>in</strong>son’s<br />
disease: does the peripheral system become central? Eur. J. Neurol. 15, 1–4.<br />
227